Dr Joint Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Dr Joint Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Store Retailers

Secondary Activities: Fats and Oils Refining and Blending | Coffee and Tea Manufacturing | General Line Grocery Merchant Wholesalers | Chemical and Allied Products Merchant Wholesalers | Miscellaneous Nondurable Goods Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Wholesale Trade Agents and Brokers | All Other Specialty Food Stores | Electronic Shopping and Mail-Order Houses

Full name: Dr Joint Sp. z o.o.

Profile Updated: May 21, 2024

Dr Joint Sp. z o.o. is an enterprise in Poland, with the main office in Kalisz. It operates in the Other Miscellaneous Store Retailers sector. Dr Joint Sp. z o.o. was incorporated on July 19, 2021.

Headquarters
Ul. Prymasa Stefana Wyszynskiego 1B
Kalisz; Wielkopolskie; Postal Code: 62-800

Contact Details: Purchase the Dr Joint Sp. z o.o. report to view the information.

Website: http://www.drjoint.pl

Basic Information

Outstanding Shares:

Purchase the Dr Joint Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Dr Joint Sp. z o.o. report to view the information.

Incorporation Date:

July 19, 2021

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Management Board Member

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Dr Joint Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating profit (EBIT)

-577.69%▼

Net Profit (Loss) for the Period

-577.69%▼

Total equity

-390.33%▼

Return on Equity (ROE)

22.01%▲